Filing Flows › Comparisons › SLSN vs YCBD
Solesence vs cbdMD: SLSN and YCBD compared
Solesence is the larger company: $15.3M of revenue in its latest quarter (Q2 2026) against $5.6M for cbdMD (Q3 FY26). cbdMD is growing faster (+21% against -25% a year earlier). Solesence is more profitable, with an operating margin of 0.8% against -20.4%.
Where the money goes: SLSN and YCBD
Solesence (SLSN) · Q2 2026
Solesence, Q2 2026: revenue $15.3M (-25% year over year), operating margin 0.8%, net loss $158K, operating cash flow $191K. The chart follows the revenue to costs, profit and cash.
cbdMD (YCBD) · Q3 FY26
cbdMD, Q3 FY26: revenue $5.6M (+21% year over year), operating margin -20.4%, net loss $1.1M, operating cash flow −$442K. The chart follows the revenue to costs, profit and cash.
| Solesence (SLSN) | cbdMD (YCBD) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 FY26 |
| Revenue | $15.3M | $5.6M |
| Revenue growth, Y/Y | -25% | +21% |
| Operating margin | 0.8% | -20.4% |
| Net earnings | −$158K | −$1.1M |
| Net margin | -1.0% | -20.3% |
| Operating cash flow | $191K | −$442K |
Where the revenue comes from
Solesence
- Product: $15.3M (100%)
- Product and Service, Other: $46K (0%)
- Advanced Materials: $41K (0%)
Questions
Which is bigger, Solesence or cbdMD?
Solesence is the larger company: $15.3M of revenue in its latest quarter (Q2 2026) against $5.6M for cbdMD (Q3 FY26).
Is Solesence or cbdMD growing faster?
cbdMD is growing faster (+21% against -25% a year earlier).
Which is more profitable, Solesence or cbdMD?
Solesence is more profitable, with an operating margin of 0.8% against -20.4%.
More: Solesence earnings · how Solesence makes money · cbdMD earnings · how cbdMD makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 19, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.